Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to GastroEsophageal Cancer
Related studies linked through entity extraction aliases.
A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
- Status
- COMPLETED
- Phase
- PHASE1
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT
- Status
- COMPLETED
- Phase
- PHASE3
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2